Viveve Medical, Inc. (VIVE)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Sep 25, 2025, 8:00 PM EDT
Viveve Medical Market Cap
Viveve Medical has a market cap or net worth of $2.15 thousand as of October 2, 2025. Its market cap has decreased by -86.63% in one year.
Market Cap
2.15K
Enterprise Value
n/a
Revenue
6.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 27, 2013, Viveve Medical's market cap has decreased from 508.17B to 2.15K, a decrease of -100.00%. That is a compound annual growth rate of -79.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 2.15K | 0.28% |
| Dec 31, 2024 | 2.15K | - |
| Dec 29, 2023 | 2.15K | -99.95% |
| Dec 30, 2022 | 4.56M | -62.29% |
| Dec 31, 2021 | 12.09M | 18.44% |
| Dec 31, 2020 | 10.21M | 101.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Tian'an Technology Group | 718.73M |
| Elite Pharmaceuticals | 713.40M |
| Glass House Brands | 598.71M |
| Northwest Biotherapeutics | 378.06M |
| CytoDyn | 326.79M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 273.17M |